IPSS-R intermediate risk
Showing 26 - 50 of >10,000
Non-hodgkin Lymphoma, Hodgkin Lymphoma Trial in Valhalla (DOC Group B, Pv-COMRAD 1 and 2 Group B, Pv-R-CYM 1 and 2 Group B)
Recruiting
- Non-hodgkin Lymphoma
- Hodgkin Lymphoma
- DOC Group B
- +16 more
-
Valhalla, New YorkNew York Medical College
Jun 9, 2022
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Boston (Venetoclax, Obinutuzumab, Acalabrutinib)
Recruiting
- Chronic Lymphocytic Leukemia
- Small Lymphocytic Lymphoma
- Venetoclax
- +2 more
-
Boston, Massachusetts
- +2 more
Aug 9, 2021
MDS Trial in United States (Pracinostat, Azacitidine)
Terminated
- Myelodysplastic Syndromes
-
Duarte, California
- +24 more
Feb 4, 2022
Myelodysplastic Syndrome Trial in France, Germany, Spain (Lenalidomide, Placebo)
Active, not recruiting
- Myelodysplastic Syndrome
- Lenalidomide
- Placebo
-
Strasbourg, Bajo Rin, France
- +24 more
Nov 22, 2021
Oropharyngeal Squamous Cell Carcinoma Trial in Worldwide (Radiation, Cisplatin, Durvalumab)
Recruiting
- Oropharyngeal Squamous Cell Carcinoma
- Radiation
- +3 more
-
Brussels, Belgium
- +25 more
Aug 8, 2022
Chemo Effect, Rectal Cancer Trial in Guangzhou (Radical total mesorectal excision, Salavge Adjuvant Chemoradiotherapy)
Recruiting
- Chemotherapy Effect
- Rectal Cancer
- Radical total mesorectal excision
- Salavge Adjuvant Chemoradiotherapy
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Sep 12, 2023
Prostate Cancer Trial in Greenfield Park (HDR brachytherapy as monotherapy)
Completed
- Prostate Cancer
- HDR brachytherapy as monotherapy
-
Greenfield Park, Quebec, CanadaHôpital Charles LeMoyne
Mar 15, 2022
Prostate Adenocarcinoma Trial (De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac)
Not yet recruiting
- Prostate Adenocarcinoma
- De-escalated radiotherapy to be delivered on the Elekta Unity Unity MR-linac
- (no location specified)
Jan 23, 2023
REVLIMID® Treatment of IPSS Low- or Intermediate-1-risk
Recruiting
- Myelodysplastic Syndromes
- +2 more
-
Anyang, Korea, Republic of
- +12 more
Apr 6, 2021
Prostate Cancer Trial in New York (IRE & MRgRT)
Recruiting
- Prostate Cancer
- IRE & MRgRT
-
New York, New YorkWeill Cornell Medicine
Aug 1, 2022
MDS Trial in Worldwide (Magrolimab, Azacitidine, Placebo)
Active, not recruiting
- Myelodysplastic Syndromes
- Magrolimab
- +2 more
-
Birmingham, Alabama
- +168 more
Dec 7, 2022
Localized Prostate Carcinoma, Castration-Naive Prostate Cancer, Intermediate Risk Prostate Cancer Trial in Turku (Degarelix,
Not yet recruiting
- Localized Prostate Carcinoma
- +3 more
- Degarelix
- MRI-guided transurethral ultrasound ablation (TULSA)
-
Turku, Southwest Finland, FinlandTurku University Hospital
Jun 14, 2023
ABlative Radiotherapy (for) Unfavorable Prostate Tumors
Recruiting
- Prostate Cancer
-
Monza, MB, ItalyRadiation Oncology, ASST Monza (University of Milan Bicocca)
Jul 21, 2022
Recurrent DLBCL, Recurrent Mantle Cell Lymphoma, Refractory DLBCL Trial in Duarte (Autologous
Active, not recruiting
- Recurrent Diffuse Large B-Cell Lymphoma
- +4 more
- Autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 28, 2022
Prostate Cancer Stage I Trial in Torino (Katty focal therapy)
Completed
- Prostate Cancer Stage I
- Katty focal therapy
-
Torino, TO, ItalyA.O.U. San Giovanni Battista Molinette
Jan 31, 2023
Aplastic Anemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Houston (Anti-Thymocyte Globulin,
Recruiting
- Aplastic Anemia
- +3 more
- Anti-Thymocyte Globulin
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Dec 1, 2021
Prostate Cancer, Radiotherapy Side Effect, Hypofractionation Trial in Quebec (grade and compare reported side effects between
Recruiting
- Prostate Cancer
- +5 more
- grade and compare reported side effects between groups
-
Quebec, CanadaCHUdeQuebec
Mar 14, 2023
Prostate Adenocarcinoma, Localized Prostate Carcinoma Trial in San Francisco (High Dose Rate Monotherapy)
Not yet recruiting
- Prostate Adenocarcinoma
- Localized Prostate Carcinoma
- High Dose Rate Monotherapy
-
San Francisco, CaliforniaUniversity of California, San Francisco
Dec 27, 2022
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
Prostate Cancer Trial in Québec (Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant, Stereotactic Body
Recruiting
- Prostate Cancer
- Low-Dose Rate Brachytherapy to the prostate using Iodine-125 seed implant
- Stereotactic Body Radiation Therapy to the prostate
-
Québec, CanadaCentre Intégré de Cancérologie, CHU de Québec-Université Laval
Sep 21, 2023
Prostate Cancer, Adverse Effects Surgery, MRI Trial in Hialeah (TRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of
Recruiting
- Prostate Cancer
- +8 more
- TRANBERG® Transperineal Fusion Laser--Induced Thermal Therapy of Prostate Cancer (TPF-LITT)
-
Hialeah, FloridaUrology Specialist Group
Jan 24, 2023